NFSG
SKYE icon

Newbridge Financial Services Group’s Skye Bioscience SKYE Stock Holding History

Newbridge Financial Services Group’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 1226
2026
Q1 		– Sell
-2
Closed -$13 – 1181
2025
Q4 		$13 Hold
2
– – ﹤0.01% 1169
2025
Q3 		$71 Hold
2
– – ﹤0.01% 1265
2025
Q2 		$75 Hold
2
– – ﹤0.01% 1289
2025
Q1 		$29 Hold
2
– – ﹤0.01% 1030
2024
Q4 		$51 Hold
2
– – ﹤0.01% 1118
2024
Q3 		$70 Hold
2
– – ﹤0.01% 643
2024
Q2 		$144 Buy
+2
New +$190 ﹤0.01% 1054

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Newbridge Financial Services Group's SKYE Position: Q2 2026 in Review

Newbridge Financial Services Group held its Skye Bioscience (SKYE) position steady in Q2 2026 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Newbridge Financial Services Group first reported a position in SKYE in Q2 2024 and has held it in 7 quarters since. The position peaked at $144 in Q2 2024. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Newbridge Financial Services Group held 0 shares of Skye Bioscience worth $1 as of Q2 2026.
  • Newbridge Financial Services Group left its Skye Bioscience share count unchanged in Q2 2026.
  • Skye Bioscience made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #1226 holding.
  • Newbridge Financial Services Group first reported a position in Skye Bioscience in Q2 2024 and has held it in 7 quarters since.
  • Newbridge Financial Services Group's Skye Bioscience position peaked at $144 in Q2 2024.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.